Synthesis and Characterization of Multifunctional Nanovesicles Composed of POPC Lipid Molecules for Nuclear Imaging.
NOTA
PET
POPC
drug delivery
gallium-68
liposome
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
30 Oct 2021
30 Oct 2021
Historique:
received:
05
10
2021
revised:
26
10
2021
accepted:
27
10
2021
entrez:
13
11
2021
pubmed:
14
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
The integration of nuclear imaging analysis with nanomedicine has tremendously grown and represents a valid and powerful tool for the development and clinical translation of drug delivery systems. Among the various types of nanostructures used as drug carriers, nanovesicles represent intriguing platforms due to their capability to entrap both lipophilic and hydrophilic agents, and their well-known biocompatibility and biodegradability. In this respect, here we present the development of a labelling procedure of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine)-based liposomes incorporating an ad hoc designed lipophilic NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid) analogue, derivatized with an oleic acid residue, able to bind the positron emitter gallium-68(III). Based on POPC features, the optimal conditions for liposome labelling were studied with the aim of optimizing the Ga(III) incorporation and obtaining a significant radiochemical yield. The data presented in this work demonstrate the feasibility of the labelling procedure on POPC liposomes co-formulated with the ad hoc designed NOTA analogue. We thus provided a critical insight into the practical aspects of the development of vesicles for theranostic approaches, which in principle can be extended to other nanosystems exploiting a variety of bioconjugation protocols.
Identifiants
pubmed: 34770999
pii: molecules26216591
doi: 10.3390/molecules26216591
pmc: PMC8587727
pii:
doi:
Substances chimiques
Drug Carriers
0
Liposomes
0
Phosphatidylcholines
0
1-palmitoyl-2-oleoylphosphatidylcholine
TE895536Y5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fondazione Umberto Veronesi
ID : xx
Références
Mol Pharm. 2017 Feb 6;14(2):406-414
pubmed: 28029258
Nucl Med Biol. 2010 Apr;37(3):265-75
pubmed: 20346866
Biomol Eng. 2001 Oct 31;18(4):143-77
pubmed: 11576871
Adv Pharm Bull. 2017 Apr;7(1):3-9
pubmed: 28507932
Biomaterials. 2012 May;33(14):3770-82
pubmed: 22357152
J Med Chem. 2002 Aug 1;45(16):3458-64
pubmed: 12139456
Nucl Med Mol Imaging. 2010 Dec;44(4):233-40
pubmed: 24899958
Expert Opin Drug Deliv. 2016 Sep;13(9):1231-42
pubmed: 27351233
Sci Rep. 2019 May 7;9(1):7006
pubmed: 31065032
ACS Biomater Sci Eng. 2018 Jan 8;4(1):163-174
pubmed: 33418686
Bioconjug Chem. 2012 Apr 18;23(4):671-82
pubmed: 22242601
Mol Pharm. 2014 Nov 3;11(11):3777-97
pubmed: 24865108
Sci Rep. 2017 Mar 28;7:45236
pubmed: 28349991
Bioconjug Chem. 2012 Apr 18;23(4):758-70
pubmed: 22369596
J Liposome Res. 2010 Sep;20(3):219-27
pubmed: 19863193
Soft Matter. 2020 Dec 14;16(46):10425-10438
pubmed: 33165495
Molecules. 2015 Jul 16;20(7):12913-43
pubmed: 26193247
Drug Discov Today. 2014 Jul;19(7):936-48
pubmed: 24434047
Contrast Media Mol Imaging. 2008 Mar-Apr;3(2):67-77
pubmed: 18383558
Pharmaceuticals (Basel). 2019 Sep 26;12(4):
pubmed: 31561546
J Nucl Med. 2008 Jun;49 Suppl 2:113S-28S
pubmed: 18523069
Theranostics. 2013 Dec 10;4(1):47-80
pubmed: 24396515
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5364-7
pubmed: 18835159
Pharmaceutics. 2021 Jul 27;13(8):
pubmed: 34452113
Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):978-81
pubmed: 17333177
Toxicol Res. 2013 Mar;29(1):1-6
pubmed: 24278622
Nano Today. 2009 Oct 1;4(5):399-413
pubmed: 20161038